Page last updated: 2024-08-21

brocresine and Disease Models, Animal

brocresine has been researched along with Disease Models, Animal in 2 studies

*Disease Models, Animal: Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. [MeSH]

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lingappa, JR; Zigmond, RE1
Ben Shachar, D; Stephenson, G; Youdim, MB1

Other Studies

2 other study(ies) available for brocresine and Disease Models, Animal

ArticleYear
Limited recovery of pineal function after regeneration of preganglionic sympathetic axons: evidence for loss of ganglionic synaptic specificity.
    The Journal of neuroscience : the official journal of the Society for Neuroscience, 2013, Mar-13, Volume: 33, Issue:11

    Topics: Animals; Arylalkylamine N-Acetyltransferase; Autonomic Nervous System Diseases; Axons; Biophysics; Brocresine; Circadian Rhythm; Disease Models, Animal; Dose-Response Relationship, Drug; Electric Stimulation; Enzyme Inhibitors; Gene Expression Regulation, Enzymologic; Isoproterenol; Male; Nerve Regeneration; Nordefrin; Pineal Gland; Rats; Rats, Sprague-Dawley; Superior Cervical Ganglion; Sympathomimetics; Time Factors; Tyrosine 3-Monooxygenase

2013
Ironing iron out in Parkinson's disease and other neurodegenerative diseases with iron chelators: a lesson from 6-hydroxydopamine and iron chelators, desferal and VK-28.
    Annals of the New York Academy of Sciences, 2004, Volume: 1012

    Topics: 3,4-Dihydroxyphenylacetic Acid; Analysis of Variance; Animals; Behavior, Animal; Brain; Brocresine; Chromatography, High Pressure Liquid; Deferoxamine; Disease Models, Animal; Dopamine; Dopamine Agents; Dose-Response Relationship, Drug; Drug Interactions; Enzyme Inhibitors; Exploratory Behavior; Functional Laterality; Homovanillic Acid; Iron; Iron Chelating Agents; Levodopa; Male; Motor Activity; Neurodegenerative Diseases; Neurotransmitter Agents; Oxidopamine; Parkinson Disease; Piperazines; Quinolines; Rats; Rats, Sprague-Dawley; Time Factors

2004